Sentences with phrase «nuclear imaging for»

Nuclear Imaging for Animals is a state - of - the - art medical imaging facility where we use radioactive tracers to perform nuclear scanning (scintigraphy) for diagnosing of thyroid, bone, liver, and kidney diseases in dogs and cats.

Case presentations are used to illustrate applications of nuclear imaging for some of the more common malignancies

Not exact matches

Earlier this year, Mallinckrodt completed a sale of its nuclear imaging business to IBA Molecular for around $ 690 million.

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

The former is ideal for soft - tissue contrast, and the latter has extremely fine imaging resolution due to a revolution in the technology called dynamic nuclear spin polarization, which is used to track minute biochemistry in the body — such as the transition of the naturally occurring chemical pyruvate to lactate.

In a related editor's note, JAMA Internal Medicine Editor - in - Chief Rita F. Redberg, M.D., M.Sc., writes: «These findings suggest that the current practice of performing a stress test on low - risk patients in the ED is unnecessary and prolongs the length of stay in EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaging.

A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

Unfortunately, nature is not always willing to easily part with its secrets, forcing scientists to rely on sophisticated imaging technology — nuclear magnetic resonance (NMR) spectroscopy or mass spectrometry, for example — to decipher the molecular formula of newly discovered organic compounds so they can be replicated in the lab.

In particular, new developments in emission tomography, nuclear magnetic resonance imaging, and in vivo spectroscopy offer new horizons for medical research and clinical activities.

Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.

Cumulative radiation exposure was also lower for patients who received CTA compared to nuclear imaging.

Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have demonstrated that diamonds may hold the key to the future for nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) technologies

While these imaging procedures, including fluoroscopically guided procedures such as cardiac catheterization, computed tomography scans, and nuclear medicine studies, are critical for accurate diagnosis and intervention, ionizing radiation in high doses can be harmful.

It also underscores the utility of solid - state nuclear magnetic resonance (NMR) spectroscopy for imaging the structures of proteins associated with prion diseases.

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

SNMMI's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice.

With its innovative Clinical Trials Network, influential annual meeting and high - impact journals, SNMMI encourages and facilitates research and science for the nuclear medicine and molecular imaging field.

Baltimore, Md. (Embargoed until 12:30 pm EDT on Monday, June 8)-- A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

SNMMI's Outreach Program offers online lectures for referring physicians to increase their understanding of how to best integrate nuclear medicine and molecular imaging into the diagnosis, staging, and treatment of patients.

SNMMI's 18,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice.

During the 495th Brookhaven Lecture, Istvan Dioszegi discussed the principles of neutron imaging and advancements to verify nuclear warheads, as well as why and how the technique might become a tool for verification under terms of the New START treaty.

Having grown to know the analytical technique of nuclear magnetic resonance as NMR, I was intrigued to discover that in medical imaging it now goes under the name of MRI, which stands for magnetic resonance imaging.

Image Gently and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) created the «Go With the Guidelines» awareness campaign to encourage community hospitals, academic hospitals and clinics to observe standardized guidelines on radiopharmaceutical dose for pediatric patients.

The Abcam product offering for fluorescent imaging continues with a selection of fluorescent dyes that are specific for nuclear counterstaining.

The Pediatric Imaging Council provides a conduit for the sharing and dissemination of information unique to pediatric nuclear medicine.

Each year, the SNMMI and SNMMI - TS join forces with the nuclear medicine and molecular imaging community to gain recognition and support for the field.

SNMMI NET Roadshow Advances in Nuclear Imaging and Therapy for Neuroendocrine Tumors August 24, 2017 Grand America Hotel Seattle, WA

This award is funded through an endowed gift given to the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) by the Dr. Michael J. Welch Foundation in memoriam of Professor Michael J. Welch, PhD, who passed away in 2012.

SNMMI - TS's Vision: To ensure that nuclear medicine and molecular imaging technology are an integral part of the standard of care for patient diagnosis, treatment and therapy.

Download the Nuclear Medicine and Molecular Imaging Week Toolkit for helpful resources.

The Therapy Center of Excellence is pleased to offer the Young Investigator Awards (YIAs) which are supported by grants from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF).

Further to my research and clinical activities, as President of the World Federation of Nuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA aNuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA aNuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA anuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA and WHO.

These fellowships are made possible through a grant from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging.

Alain Destexhe, Research Director of Unité de Neurosciences CNRS, Gif - sur - Yvette, France Bruno Weber, Professor of Multimodal Experimental Imaging, Universitaet Zuerich, Switzerland Carmen Gruber Traub, Fraunhofer, Germany Costas Kiparissides, Certh, Greece Cyril Poupon, Head of the Nuclear Magnetic Resonance Imaging and Spectroscopy unit of NeuroSpin, University Paris Saclay, Gif - sur - Yvette, France David Boas, Professor of Radiology at Massachusetts General Hospital, Harvard Medical School, University of Pennsylvania Hanchuan Peng, Associate Investigator at Allen Brain Institute, Seattle, US Huib Manswelder, Head of Department of Integrative Neurophysiology Center for Neurogenomics and Cognitive Research, VU University, Amsterdam Jan G. Bjaalie, Head of Neuroinformatics division, Institute of Basic Medical Sciences, University of Oslo, Norway Jean - François Mangin, Research Director Neuroimaging at CEA, Gif - sur - Yvette, France Jordi Mones, Institut de la Macula y la Retina, Barcelona, Spain Jurgen Popp, Scientific Director of the Leibniz Institute of Photonic Technology, Jena, Germany Katharina Zimmermann, Hochshule, Germany Katrin Amunts, Director of the Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Leslie M. Loew, Professor at University of Connecticut Health Center, Connecticut, US Marc - Oliver Gewaltig, Section Manager of Neurorobotics, Simulation Neuroscience Division - Ecole Polytechnique fédérale de Lausanne (EPFL), Geneve, Switzerland Markus Axer, Head of Fiber architecture group, Institute of Neuroscience and Medicine (INM - 1) at Forschungszentrum Juelich, Germany Mickey Scheinowitz, Head of Regenerative Therapy Department of Biomedical Engineering and Neufeld Cardiac Research Institute, Tel - Aviv University, Israel Pablo Loza, Institute of Photonic Sciences, Castelldefels, Spain Patrick Hof, Mount Sinai Hospital, New York, US Paul Tiesinga, Professor at Faculty of Science, Radboud University, Nijmegen, Netherlands Silvestro Micera, Director of the Translational Neural Engineering (TNE) Laboratory, and Associate Professor at the EPFL School of Engineering and the Centre for Neuroprosthetics Timo Dicksheid, Group Leader of Big Data Analytics, Institute Structural and functional organisation of the brain, Forschungszentrum Juelich, Germany Trygve Leergaard, Professor of Neural Systems, Institute of Basic Medical Sciences, University of Oslo, Norway Viktor Jirsa, Director of the Institute de Neurosciences des Systèmes and Director of Research at the CNRS, Marseille, France

Specifically, I am leading a Project focusing on Nitrogen - Vacancy centers in nanostructured diamond as a means to hyperpolarize nuclear spins for the production of hyperpolarized agents for imaging of cells and tissues in living organisms.

Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?

Radiation dose for all nuclear medicine and molecular imaging procedures should be optimized so that the patient receives the smallest possible amount of radiopharmaceutical that will provide the appropriate diagnostic information.

SNMMI Position Statement on Dose Optimization for Nuclear Medicine and Molecular Imaging Procedures

For example, nanoDESI will be used for analysis of oil samples and chemical imaging of Shewanella oneidensis, a common microbe of interest to cleaning up contaminated nuclear weapons sitFor example, nanoDESI will be used for analysis of oil samples and chemical imaging of Shewanella oneidensis, a common microbe of interest to cleaning up contaminated nuclear weapons sitfor analysis of oil samples and chemical imaging of Shewanella oneidensis, a common microbe of interest to cleaning up contaminated nuclear weapons sites.

The SNMMI Future Leaders Academy training focuses on setting a clear plan for increasing leadership abilities by developing the necessary skills and organizational expertise to enhance performance and ultimately evolve into a leader both within the nuclear medicine and molecular imaging community and the society.

The guide summarizes the indications and applications of molecular imaging and nuclear medicine for diagnosis, staging, and therapy of malignancy.

The SNMMI Bradley - Alavi Student Fellowships are designed to stimulate students» interest in molecular imaging / nuclear medicine by supporting their full - time participation in clinical and basic research activities for three months (or less).

This ceremony will bring together the winner from each country along with the Leadership of the Society to celebrate the extraordinary work that is being done around the globe to further the effectiveness of nuclear medicine and molecular imaging and ultimately to contribute to better diagnosis and treatment for patients.

Our work would allow large - scale quantum information processing and quantum simulation on nuclear spin qubits, as well as atomic - scale imaging for biomolecules.

The Professional Development and Education Fund (PDEF) for the Society of Nuclear Medicine and Molecular Imaging - Technologist Section AND Mama's Kitchen, a local charity.

2018 Mary - Kocemba Slosky, PhD, Professional Relations Fellowship 2018 ERF SNMMI CMIIT Lab Professional Award 2018 - 2020 Wagner - Torizuka Fellowship 2018 ERF SNMMI Travel Award for Physician, Scientists, and MD / PhD Students 2018 Masahiro Iio, MD Travel Award 2018 Mitzi & William Blahd, MD, Pilot Research Grant 2018 Marc Tetalman, MD, Memorial Award 2018 ERF SNMMI - TS Travel Award for Nuclear Medicine Technologists 2018 ERF SNMMI - TS Travel Award for Nuclear Medicine Technologist Students 2018 Paul Cole Student Technologist Scholarship 2018 ERF - SNMMI Postdoctoral Molecular Imaging Scholar Program Grant

This high levels of hyperpolarization, together with the long nuclear - spin polarization lifetimes in nanodiamonds and the relatively high density of 13C nuclei, turn functionalized and hyperpolarized nanodiamonds into attractive MRI probes for molecular imaging both in vitro and in vivo.

* Based on the findings of a survey conducted at 13 premier pediatric hospitals in North America indicating administered radiopharmaceutical activities in children varied greatly, a workgroup was established representing the Society of Nuclear Medicine and Molecular Imaging (SNMMI) through the Pediatric Council, the Society for Pediatric Radiology and the Amercian College of Radiology (ACR).

SNMMI's free, daily e-mail news briefing for nuclear medicine and molecular imaging professionals.

As a neuroscientist with backgrounds in nuclear medicine (aka brain imaging) and nutrition, I'm frequently asked whether gluten is bad for your brain and whether it should be avoided.